The short version
You're not alone if you're hitting your sleep target on paper and still feeling under-rested at 9am. Eight hours of time-in-bed isn't the same as eight hours of restorative sleep, and the gap between those two widens through your thirties. The basics — cool, dark, consistent, no late caffeine, magnesium — get you to the duration. They don't necessarily get you to the depth.
The fix isn't a different sleep tracker. It's understanding what changed in your sleep architecture between 25 and 38, and which of those changes are addressable.
Why this happens
Two things change as you move through your thirties. First, slow-wave sleep — the deepest, most physiologically restorative stage — declines measurably with age. Multiple studies on sleep architecture across the lifespan document the same trend: time-in-bed can stay constant while time-in-deep-sleep drops. Second, the hormone cascades that drive overnight repair shift. Endogenous growth hormone secretion peaks during slow-wave sleep, and total daily GH output declines with age along a fairly predictable curve. Less deep sleep means less of the hormonal work sleep is supposed to be doing.
Layer on cortisol that doesn't always settle the way it did a decade ago, and you can hit the duration target while missing the underlying restoration. The number on the wearable looks fine. The morning still doesn't.
Hygiene gets you the duration. The depth is a different problem.
What the basics miss
Sleep hygiene is real and it works for most people most of the time. The reason it stops feeling sufficient isn't that the advice is wrong — it's that hygiene addresses the inputs (timing, environment, behavior) and not the outputs (depth, hormone cascade, recovery). When the basics aren't moving the needle anymore, it's usually because the rate-limiting factor has shifted from the inputs to the architecture itself.
The supplement shelf has a similar limit. Magnesium, glycine, theanine, ashwagandha, exogenous melatonin — each addresses a specific input. None of them rebuild slow-wave sleep architecture in someone whose physiology has shifted. They're not bad; they're just operating one layer up from where the actual problem lives.
What a prescription pathway adds
A provider looking at the same picture can ask different questions. Are we looking at a hormone-cascade issue worth supporting? Is sleep-disordered breathing in the differential — and has it been ruled in or out? Are there labs that would change the protocol? Is a peptide protocol that supports endogenous GH pulse during slow-wave sleep a reasonable adjunct, and on what timeline?
None of those questions have a single right answer for everyone. They're a clinical conversation that the supplement aisle can't have. Boswell's role here is the prescription pathway: a U.S.-licensed physician evaluating whether peptides like sermorelin or CJC-1295 + Ipamorelin make sense for your situation, with a 503A pharmacy compounding the prescription. Peptides and sleep is the goal hub. Sermorelin and CJC-1295 + Ipamorelin cover the specific compounds, and a side-by-side comparison walks the differences.
Questions worth asking your provider
- Have we ruled out sleep-disordered breathing — is a sleep study indicated?
- What labs would help interpret the daytime fog — thyroid, ferritin, sex hormones, IGF-1?
- Is the issue duration, depth, or fragmentation — and how do we tell?
- Does a growth-hormone-secretagogue protocol fit my situation, and what would the response window look like?
- What's the simplest version of this protocol we could try first?
Sources